Document is current
Any future updates will be listed below
-
Authors
Strayer, Ethan C. https://orcid.org/0000-0003-3612-741X
Krishna, Srikar https://orcid.org/0000-0001-7383-2252
Lee, Haejeong https://orcid.org/0000-0001-5243-7595
Vejnar, Charles https://orcid.org/0000-0002-7132-4534
Neuenkirchen, Nils https://orcid.org/0000-0002-5274-0487
Gupta, Amit
Beaudoin, Jean-Denis https://orcid.org/0000-0003-4932-1668
Giraldez, Antonio J. https://orcid.org/0000-0002-6823-137X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM1225, R35 GM146883)
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD100035)
- License Information
-
More Information
Article History
Received: 28 November 2023
Accepted: 6 December 2024
First Online: 30 December 2024
Competing interests
: E.C.S., J.-D.B., S.K., and A.J.G are inventors on a provisional patent application filed by Yale University with the US patent office covering the NaP-TRAP method and the sequences described here. A.J.G. is founder of and has equity an equity interest in RESA Therapeutics, Inc. The remaining authors declare no competing interests.
